SPOTLIGHT: Big4Bio:SFBay 2020 Year-in-Review

Welcome to the 2020 Big4Bio Year-in-Review for the San Francisco Bay Area! We hope you enjoy looking back on 2020’s top stories, deals, and M&A that went down in SFBay’s research, pharma, and biotech sectors as we head into 2021. Here’s what you’ll find inside the Year-in-Review 2020 report: Facts about the Bay Area’s life […]

Read More

Spotlight Q&A: TFF Pharmaceuticals – Innovative Drug Formulation May Expand Geographic Reach of COVID-19 Vaccines and Treatments

LaVoieHealthScience Client Spotlight Following is a Q&A with Glenn Mattes, President, CEO and Director of TFF Pharmaceuticals (Nasdaq: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform. Welcome to Big4Bio, Mr. Mattes. Can you share with our readers what is important about […]

Read More

Spotlight Q&A: Outlook Therapeutics — Developing First Ophthalmic Formulation of Bevacizumab for FDA Approval

LaVoieHealthScience Client Spotlight Following is a Q&A with Lawrence Kenyon, President, CEO and CFO of Outlook Therapeutics (NASDAQ: OTLK), a late-stage clinical biotech company focused on developing the first FDA-approved ophthalmic formulation of bevacizumab-vikg to treat wet age-related macular degeneration (wet AMD) and other retinal diseases.  By way of background for our readers, age-related macular […]

Read More

Big4Bio Q&A: Dror Bashan, CEO of Protalix BioTherapeutics

LaVoieHealthScience Client Spotlight with Dror Bashan, CEO of Protalix BioTherapeutics Can you provide a brief overview of Protalix BioTherapeutics and its focus? Protalix BioTherapeutics is a unique biopharmaceutical company dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based expression. Protalix was the first company ever to gain FDA approval for […]

Read More

Spotlight: Explora BioLabs — Powering Your Science

Explora BioLabs provides preclinical, AAALAC-accredited vivarium space and related services to clients of all sizes and in all stages of development. With 150,000 square feet of space across 11 locations in biotech-dense communities, the company prides itself on providing clients the ability to initiate preclinical in vivo programs in as little as two weeks, with […]

Read More

Big4Bio:SFBay COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]

Read More

GigaGen Focuses Its Technology to Address COVID-19 Pandemic

by Marie Daghlian GigaGen announced that it is developing a recombinant polyclonal antibody therapy for the treatment of COVID-19, the pandemic coronavirus that has been sweeping the world and for which humans have no innate immunity. Based in South San Francisco, GigaGen spent the first seven years of its existence developing its single cell technology […]

Read More

SPOTLIGHT: Big4Bio:SFBay 2019 Year-in-Review

Welcome to the first-ever Big4Bio Year-in-Review for the San Francisco Bay Area! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in San Francisco Bay’s research, pharma, and biotech industries as you look ahead to a fruitful 2020. Here’s what you’ll find inside the Year-in-Review 2019 report: Data […]

Read More

Big4Bio Interview with Halloran Consulting Group’s Laurie Halloran and Katie McCarthy

Boston-based Halloran Consulting Group offers senior-level expertise to life science companies as they navigate the regulatory, clinical, and operational challenges at each stage of their development. At the beginning of October, Halloran announced several promotions in its organization, and the expansion of operations in San Diego, setting up a West Coast office there to better […]

Read More

Spotlight: Catching Up With CO.DON AG CEO, Ralf Jakobs

LaVoieHealthScience Client Spotlight: CO.DON CEO, Ralf Jakobs — Advancing Autologous Human Cell Transplants   Can you provide a brief overview of CO.DON and its focus? CO.DON is focused on the development, production and marketing of cell-based products for joint-preserving, regenerative treatment of articular cartilage defects. That’s all we do and where we have built our […]

Read More

Spotlight: Q&A With Scott Grossman on ExL Events

ExL Events, a division of Questex, develops and hosts content-driven conferences and partnered events for life sciences industry professionals and academia that cover a breadth of topics from drug and device development issues and services, to hospital networks, communications, and human resources.  Their diverse event portfolio is backed by extensive market research and targeted outreach […]

Read More

An Update on Big4Bio’s LinkedIn Groups

As Big3Bio rebrands to Big4Bio, the organization’s LinkedIn presence will also be reshaped. LinkedIn groups have the potential to instigate meaningful discussions among members of the community. In the past, Big3Bio has cultivated three region–specific groups, Boston, San Diego, and SFBay. But with Big3Bio rebranding to Big4Bio, we have made the decision to unify the […]

Read More

Spotlight: Big3Bio Announces Upcoming Launch of Philadelphia as a New Region of Coverage; Will Rebrand as Big4Bio

– Big4Bio:Philly to Recap Life Science Developments in the Greater Philadelphia Region; To Launch During BIO International Convention in Philadelphia in June – All “Big3Bio” Regional Sites of Boston, SFBay, San Diego to Come Together Into New “Big4Bio.com” Website With Philadelphia to Be Included BigBio Communications is proud to announce the upcoming expansion and rebranding […]

Read More

Spotlight: Advance Biotech Grant Program

Unlock your molecule’s potential. Apply to the US and Canada Advance Biotech Grant Program Your promising molecule requires resources and support to realize it’s potential. Our Advance Biotech Grant Program, 6th edition, is open to biotech start-up companies in US and Canada to help you accelerate to clinic faster. Apply now for a chance to win […]

Read More